257 related articles for article (PubMed ID: 29859935)
1. Exosomal miR-93 promotes proliferation and invasion in hepatocellular carcinoma by directly inhibiting TIMP2/TP53INP1/CDKN1A.
Xue X; Wang X; Zhao Y; Hu R; Qin L
Biochem Biophys Res Commun; 2018 Aug; 502(4):515-521. PubMed ID: 29859935
[TBL] [Abstract][Full Text] [Related]
2. Mechanism of exosomal microRNA-224 in development of hepatocellular carcinoma and its diagnostic and prognostic value.
Cui Y; Xu HF; Liu MY; Xu YJ; He JC; Zhou Y; Cang SD
World J Gastroenterol; 2019 Apr; 25(15):1890-1898. PubMed ID: 31057302
[TBL] [Abstract][Full Text] [Related]
3. Exosomal MiR-744 Inhibits Proliferation and Sorafenib Chemoresistance in Hepatocellular Carcinoma by Targeting PAX2.
Wang G; Zhao W; Wang H; Qiu G; Jiang Z; Wei G; Li X
Med Sci Monit; 2019 Sep; 25():7209-7217. PubMed ID: 31553714
[TBL] [Abstract][Full Text] [Related]
4. In hepatocellular carcinoma miR-519d is up-regulated by p53 and DNA hypomethylation and targets CDKN1A/p21, PTEN, AKT3 and TIMP2.
Fornari F; Milazzo M; Chieco P; Negrini M; Marasco E; Capranico G; Mantovani V; Marinello J; Sabbioni S; Callegari E; Cescon M; Ravaioli M; Croce CM; Bolondi L; Gramantieri L
J Pathol; 2012 Jul; 227(3):275-85. PubMed ID: 22262409
[TBL] [Abstract][Full Text] [Related]
5. Development and validation of serum exosomal microRNAs as diagnostic and prognostic biomarkers for hepatocellular carcinoma.
Xue X; Zhao Y; Wang X; Qin L; Hu R
J Cell Biochem; 2019 Jan; 120(1):135-142. PubMed ID: 30238497
[TBL] [Abstract][Full Text] [Related]
6. Downregulation of serum exosomal miR-320d predicts poor prognosis in hepatocellular carcinoma.
Li W; Ding X; Wang S; Xu L; Yin T; Han S; Geng J; Sun W
J Clin Lab Anal; 2020 Jun; 34(6):e23239. PubMed ID: 32125733
[TBL] [Abstract][Full Text] [Related]
7. Acidic Microenvironment Up-Regulates Exosomal miR-21 and miR-10b in Early-Stage Hepatocellular Carcinoma to Promote Cancer Cell Proliferation and Metastasis.
Tian XP; Wang CY; Jin XH; Li M; Wang FW; Huang WJ; Yun JP; Xu RH; Cai QQ; Xie D
Theranostics; 2019; 9(7):1965-1979. PubMed ID: 31037150
[No Abstract] [Full Text] [Related]
8. Human umbilical cord mesenchymal stem cells-derived exosomal microRNA-451a represses epithelial-mesenchymal transition of hepatocellular carcinoma cells by inhibiting ADAM10.
Xu Y; Lai Y; Cao L; Li Y; Chen G; Chen L; Weng H; Chen T; Wang L; Ye Y
RNA Biol; 2021 Oct; 18(10):1408-1423. PubMed ID: 33206588
[TBL] [Abstract][Full Text] [Related]
9. Up-regulation of miR-95-3p in hepatocellular carcinoma promotes tumorigenesis by targeting p21 expression.
Ye J; Yao Y; Song Q; Li S; Hu Z; Yu Y; Hu C; Da X; Li H; Chen Q; Wang QK
Sci Rep; 2016 Oct; 6():34034. PubMed ID: 27698442
[TBL] [Abstract][Full Text] [Related]
10. MicroRNA-608 acts as a prognostic marker and inhibits the cell proliferation in hepatocellular carcinoma by macrophage migration inhibitory factor.
Wang K; Liang Q; Wei L; Zhang W; Zhu P
Tumour Biol; 2016 Mar; 37(3):3823-30. PubMed ID: 26474589
[TBL] [Abstract][Full Text] [Related]
11. Downregulation of miR-329 promotes cell invasion by regulating BRD4 and predicts poor prognosis in hepatocellular carcinoma.
Zhou J; Li W; Guo J; Li G; Chen F; Zhou J
Tumour Biol; 2016 Mar; 37(3):3561-9. PubMed ID: 26456956
[TBL] [Abstract][Full Text] [Related]
12. Decreased levels of serum exosomal miR-638 predict poor prognosis in hepatocellular carcinoma.
Shi M; Jiang Y; Yang L; Yan S; Wang YG; Lu XJ
J Cell Biochem; 2018 Jun; 119(6):4711-4716. PubMed ID: 29278659
[TBL] [Abstract][Full Text] [Related]
13. Cancer-associated fibroblasts promote hepatocellular carcinoma progression through downregulation of exosomal miR-150-3p.
Yugawa K; Yoshizumi T; Mano Y; Itoh S; Harada N; Ikegami T; Kohashi K; Oda Y; Mori M
Eur J Surg Oncol; 2021 Feb; 47(2):384-393. PubMed ID: 32883551
[TBL] [Abstract][Full Text] [Related]
14. Over-expression of long non-coding RNA insulin-like growth factor 2-antisense suppressed hepatocellular carcinoma cell proliferation and metastasis by regulating the microRNA-520h/cyclin-dependent kinase inhibitor 1A signaling pathway.
Huang Z; Su G; Bi X; Zhang L; Xu Z; Wang G
Bioengineered; 2021 Dec; 12(1):6952-6966. PubMed ID: 34516353
[TBL] [Abstract][Full Text] [Related]
15. Upregulated miR-182 increases drug resistance in cisplatin-treated HCC cell by regulating TP53INP1.
Qin J; Luo M; Qian H; Chen W
Gene; 2014 Apr; 538(2):342-7. PubMed ID: 24447717
[TBL] [Abstract][Full Text] [Related]
16. Serum exosomal microRNAs as novel biomarkers for hepatocellular carcinoma.
Sohn W; Kim J; Kang SH; Yang SR; Cho JY; Cho HC; Shim SG; Paik YH
Exp Mol Med; 2015 Sep; 47(9):e184. PubMed ID: 26380927
[TBL] [Abstract][Full Text] [Related]
17. MicroRNA-451: epithelial-mesenchymal transition inhibitor and prognostic biomarker of hepatocelluar carcinoma.
Huang JY; Zhang K; Chen DQ; Chen J; Feng B; Song H; Chen Y; Zhu Z; Lu L; De W; Wang R; Chen LB
Oncotarget; 2015 Jul; 6(21):18613-30. PubMed ID: 26164082
[TBL] [Abstract][Full Text] [Related]
18. MiR-1202 suppresses hepatocellular carcinoma cells migration and invasion by targeting cyclin dependent kinase 14.
Du B; Zhang P; Tan Z; Xu J
Biomed Pharmacother; 2017 Dec; 96():1246-1252. PubMed ID: 29217161
[TBL] [Abstract][Full Text] [Related]
19. Exosome-Mediated MiR-155 Transfer Contributes to Hepatocellular Carcinoma Cell Proliferation by Targeting PTEN.
Sun JF; Zhang D; Gao CJ; Zhang YW; Dai QS
Med Sci Monit Basic Res; 2019 Oct; 25():218-228. PubMed ID: 31645540
[TBL] [Abstract][Full Text] [Related]
20. miR-383 inhibits hepatocellular carcinoma cell proliferation via targeting APRIL.
Chen L; Guan H; Gu C; Cao Y; Shao J; Wang F
Tumour Biol; 2016 Feb; 37(2):2497-507. PubMed ID: 26385772
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]